Literature DB >> 1352746

Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.

P Cornillet1, P Gredy, J L Pennaforte, O Meyer, M D Kazatchkine, J H Cohen.   

Abstract

The allotypic forms of the C3b/C4b receptor (CR1, CD35) differ in length, in the number of expressed C3b binding sites and thus in their ability to mediate the processing of circulating C3- and C4-bearing immune complexes. We have used a combination of three informative restriction fragment length polymorphisms (RFLPs) to assess the frequencies of the F (most frequent allele comprised of four long homologous repeats (LHR)), S (five LHR) and F' (three LHR) alleles of the C3b/C4b receptor (CR1, CD35) in a French population of patients with systemic lupus erythematosus (SLE) (n = 63) and healthy controls (n = 158). A significantly higher frequency of the S phenotype was observed among patients (51%) as compared with controls (26%). The F' allele was found in 2/61 patients and 1/85 healthy controls, indicating the rare occurrence of the short CR1 allele in SLE. This allele is also extremely rare in the normal population. The overrepresentation of the S long allele among patients is indicative of a genetic linkage between CR1 and susceptibility to SLE.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352746      PMCID: PMC1554391          DOI: 10.1111/j.1365-2249.1992.tb06871.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

Authors:  J M Ahearn; D T Fearon
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

Authors:  J A Schifferli; Y C Ng; J Estreicher; M J Walport
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

3.  Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.

Authors:  W W Wong; S A Farrell
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

4.  Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus.

Authors:  J H Cohen; V Caudwell; M Levi-Strauss; P Bourgeois; M D Kazatchkine
Journal:  Arthritis Rheum       Date:  1989-04

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.

Authors:  S Van Dyne; V M Holers; D M Lublin; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

7.  The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.

Authors:  F Moldenhauer; M Botto; M J Walport
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes.

Authors:  J G Wilson; E E Murphy; W W Wong; L B Klickstein; J H Weis; D T Fearon
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

9.  Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.

Authors:  W W Wong; J M Cahill; M D Rosen; C A Kennedy; E T Bonaccio; M J Morris; J G Wilson; L B Klickstein; D T Fearon
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Authors:  L B Klickstein; T J Bartow; V Miletic; L D Rabson; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  5 in total

1.  Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.

Authors:  B P Tsao; R M Cantor; K C Kalunian; C J Chen; H Badsha; R Singh; D J Wallace; R C Kitridou; S L Chen; N Shen; Y W Song; D A Isenberg; C L Yu; B H Hahn; J I Rotter
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis.

Authors:  Swapan K Nath; John B Harley; Young Ho Lee
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

3.  C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.

Authors:  A Kumar; A N Malaviya; S Sinha; P S Khandekar; K Banerjee; L M Srivastava
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

4.  The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.

Authors:  John V Asimakopoulos; Evangelos Terpos; Loula Papageorgiou; Olga Kampouropoulou; Dimitris Christoulas; Anastasios Giakoumis; Michael Samarkos; George Vaiopoulos; Konstantinos Konstantopoulos; Maria K Angelopoulou; Theodoros P Vassilakopoulos; John Meletis
Journal:  Med Sci Monit       Date:  2014-01-27

5.  CR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population.

Authors:  Aditya K Panda; Balachandran Ravindran; Bidyut K Das
Journal:  Lupus Sci Med       Date:  2016-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.